Amylin, a 37-amino acid peptide, is cosecreted with insulin from the b
eta-cells of the pancreatic islets in normal response to physiological
stimuli. It is the major protein of islet amyloid, which is usually p
resent in the pancreases of people with non-insulin-dependent (type II
) diabetes mellitus, Amylin elicits potent effects on carbohydrate met
abolism in rodent tissues, causing insulin resistance in skeletal musc
le and liver. A close structural relationship exists between amylin an
d the 2 calcitonin gene-related peptides, which are widely distributed
neuropeptides and potent vasodilators, These exert biological effects
similar to those of amylin on the organs primarily responsible for th
e regulation of carbohydrate metabolism. All 3 peptides are thought to
cause their biological actions by binding to similar cell surface rec
eptors. This article reviews the field of amylin and its role in the p
hysiological regulation of carbohydrate metabolism, and in disease mec
hanisms associated with insulin resistance in diabetes mellitus, impai
red glucose tolerance and essential hypertension, Potential therapeuti
c applications are also discussed.